EDGAR Filing Documents for 0001564590-18-027415

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001564590-18-027415

Filing Date

2018-11-06

Accepted

2018-11-06 16:14:03

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	ctmx-s3.htm	S-3	497311
2	EX-4.4	ctmx-ex44_26.htm	EX-4.4	486912
3	EX-5.1	ctmx-ex51_27.htm	EX-5.1	33377
4	EX-23.1	ctmx-ex231_28.htm	EX-23.1	2743
5	EX-23.2	ctmx-ex232_46.htm	EX-23.2	2207
6	GRAPHIC	g5tud43v44ta000001.jpg	GRAPHIC	58591
7	GRAPHIC	gs3zdawhf1qn000001.jpg	GRAPHIC	3631
8	GRAPHIC	g5tud43v44ta000002.jpg	GRAPHIC	58309
	Complete submission text file	0001564590-18-027415.txt		1189948

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228203 | Film No.: 181163120
SIC: 2834 Pharmaceutical Preparations